Mythic Therapeutics
Waltham
About Mythic Therapeutics
Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics. The company is pioneering a powerful protein engineering-focused approach to improving the effectiveness of antibody-drug conjugates (ADCs) and other antibody-based therapeutics. Their technology dramatically increases therapeutic potency without compromising safety, thereby unlocking the full potential of targeted therapies against a broad array of tumor targets.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $126.6M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2021)
- Website: mythictx.com
Industries & Categories
Biotechnology, Health Care, Life Science, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/mythic-therapeutics-115623 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.